Terms: = Uterine cancer AND LRIG3, Q6UXM1, 121227, ENSG00000139263, FLJ90440, KIAA3016, FLJ26573
5 results:
1. miR-196a targeting lrig3 promotes the proliferation and migration of cervical cancer cells.
Qiu Y; Han Q; Lu H; Shi C
Cell Mol Biol (Noisy-le-grand); 2020 Oct; 66(7):180-185. PubMed ID: 33287939
[TBL] [Abstract] [Full Text] [Related]
2. Expression and significance of lrig3 in human cervical squamous cell carcinoma.
Guo L; Zhang W; Sheng Y; Chen K; Shi Q; Zhang P; Zhang R
Eur J Gynaecol Oncol; 2015; 36(4):414-9. PubMed ID: 26390694
[TBL] [Abstract] [Full Text] [Related]
3. LRIG and cancer prognosis.
Lindquist D; Kvarnbrink S; Henriksson R; Hedman H
Acta Oncol; 2014 Sep; 53(9):1135-42. PubMed ID: 25180912
[TBL] [Abstract] [Full Text] [Related]
4. Immunohistochemical lrig3 expression in cervical intraepithelial neoplasia and invasive squamous cell cervical cancer: association with expression of tumor markers, hormones, high-risk HPV-infection, smoking and patient outcome.
Lindström AK; Hellberg D
Eur J Histochem; 2014 Apr; 58(2):2227. PubMed ID: 24998916
[TBL] [Abstract] [Full Text] [Related]
5. Expression of LRIG1 and lrig3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma.
Muller S; Lindquist D; Kanter L; Flores-Staino C; Henriksson R; Hedman H; Andersson S
Int J Oncol; 2013 Jan; 42(1):247-52. PubMed ID: 23165628
[TBL] [Abstract] [Full Text] [Related]
